Rabia Gurses Ozden Adverum Biotechnologies, Inc. (ADVM) insider trading activity

Rabia Gurses Ozden is Chief Medical Officer of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 0 shares of ADVM, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 8,125 shares (Common Stock - Restricted Stock Units) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

n/a 12M change

Total Value Held $0

Rabia Gurses Ozden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	8,125 Reduced 100.0%	0 Common Stock - Restric...
Dec 09 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	85,000 Reduced 100.0%	0 Common Stock - Perform...
Dec 09 2025	BUY Grant, award, or other acquisition	-	85,000 Added 50.0%	85,000 Common Stock - Perform...
Feb 25 2025	BUY Grant, award, or other acquisition	-	8,125 Added 50.0%	8,125 Common Stock

Also insider at

OCUL

OCULAR THERAPEUTIX, INC Healthcare

Chief Medical Officer

RGO